Comment · Mon, April 24, 2017 · Ceretropic & Nootropics Depot
A clarification for everyone who is interested in BPC-157
Original post in this thread
SuperAgonist · 23 points
BPC-157 is a peptide where BPC stands for Body Protective Compound. It greatly accelerates the healing of injuries and many of its actions are related to DNA repair.
If you have anhedonia/depression caused by drug abuse, you might have a brain injury that caused these problems, and therefore BPC-157 can help.
HOWEVER, if you always had anhedonia/depression, and it's just part of your DNA, BPC-157 won't cure this because your body sees your brain as healthy tissue - it has no DNA damage, the anhedonia is a normal part of your DNA, therefore BPC-157 won't fix it.
****
Example: Person A has had anhedonia his entire life, Person B has had anhedonia as a result of drug abuse. Both take BPC-157. Person B will significantly benefit because his anhedonia is a result of brain injury from drugs. Person A is unlikely to benefit since the anhedonia is just part of his genetic code, so there's nothing here to repair - this does not count as an injury in Person A (since he was born with it), it just counts as a feature.
****
TL;DR: BPC-157 is great for injuries, particularly for DNA damage, but it won't heal issues that you had from the day you were born, because they count as a norma…
What they were answering
graatch2 · 1 points
It's these acute effects which make me wonder whether this lasting reversal of amphetamine-related damage exists at all! Could people just be noticing these acute effects, perhaps from partial agonism of dopamine receptors (which could account for a number of the research findings: reduced stimulant behavior when coadministered with amphetamine, reduced sensitization, and antidepressant effects) and hyping them? It's just that the degree of restorative power attributed to this agent would make it unlike anything I have ever encountered in pharmacology. I would very much like that to exist, mind you, and I am openminded, but it's still not clear to me what this really is.
Another possibility is that people with lasting problems from psychostimulants suffer something that we might more usefully call dysregulation than damage, and BPC-157 corrects this dysregulation.
u/MisterYouAreSoDumb · Ceretropic & Nootropics Depot
It could be a combination of things. It's hard to say for sure without more data.